Literature DB >> 27565322

Silencing of ATPase family AAA domain-containing protein 2 inhibits migration and invasion of colorectal cancer cells.

S Hong, M Bi, Z Yan, D Sun, L Ling, C Zhao.   

Abstract

Colorectal cancer is one of the most common malignant tumors with a high rate of distant metastasis, postoperative recurrence and mortality. ATPase family AAA domain-containing protein 2 (ATAD2), a member of ATPase family, is highly expressed in various cancers, including colorectal cancer. However, whether ATAD2 plays a role in the migration and invasion of colorectal cancer cells remains unknown. In this study, we established ATAD2 knockdown in colorectal cancer cell lines by RNA interference and found that silencing of ATAD2 inhibited the migration and invasion ability of Caco-2 and SW-480 cells. Moreover, ATAD2 silencing suppressed epithelial-mesenchymal transition (EMT), and reduced the expression and enzymatic activity of matrix metalloproteinases (MMPs) in Caco-2 and SW-480 cells. In summary, our results suggest that silencing of ATAD2 inhibits migration and invasion of colorectal cancer cells by suppressing EMT and decreasing the activity of MMPs. Hence, ATAD2 could be considered as a novel molecular marker of metastatic colorectal cancer, and it may provide new insights for clinical diagnosis and treatment of colorectal cancer.

Entities:  

Keywords:  ATAD2; EMT MMPs.; colorectal cancer; invasion; migration

Mesh:

Substances:

Year:  2016        PMID: 27565322     DOI: 10.4149/neo_2016_603

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  8 in total

1.  Disulfide bridge formation influences ligand recognition by the ATAD2 bromodomain.

Authors:  Jamie C Gay; Brian E Eckenroth; Chiara M Evans; Cassiano Langini; Samuel Carlson; Jonathan T Lloyd; Amedeo Caflisch; Karen C Glass
Journal:  Proteins       Date:  2018-12-27

2.  NEAT1_2 functions as a competing endogenous RNA to regulate ATAD2 expression by sponging microRNA-106b-5p in papillary thyroid cancer.

Authors:  Wei Sun; Xiabin Lan; Hao Zhang; Zhihong Wang; Wenwu Dong; Liang He; Ting Zhang; Ping Zhang; Jinhao Liu; Yuan Qin
Journal:  Cell Death Dis       Date:  2018-03-07       Impact factor: 8.469

3.  Long Non-Coding RNA CRNDE Promotes Colorectal Carcinoma Cell Progression and Paclitaxel Resistance by Regulating miR-126-5p/ATAD2 Axis.

Authors:  Chang Liu; Jianfeng Hou; Fengxiao Shan; Lijuan Wang; Hanjie Lu; Tiejun Ren
Journal:  Onco Targets Ther       Date:  2020-06-02       Impact factor: 4.147

4.  Overexpression of ATAD2 indicates Poor Prognosis in Oral Squamous Cell Carcinoma.

Authors:  Xiao-Long Wang; Shuo Wang; Zhi-Zhong Wu; Qi-Chao Yang; Hao Li; Hong-Gang Xiong; Shu-Cheng Wan; Zhi-Jun Sun
Journal:  Int J Med Sci       Date:  2020-06-27       Impact factor: 3.738

5.  Prognostic value of ATPase family, AAA+ domain containing 2 expression in human cancers: A systematic review and meta-analysis.

Authors:  Hua-Jing Han; Qian-Yi Huang; Li-Jun Huang; Fan Chang; Qi-Zhi Diao
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

6.  ATAD2 predicts poor outcomes in patients with ovarian cancer and is a marker of proliferation.

Authors:  Qun Liu; Heshu Liu; Lina Li; Xiaomei Dong; Xiaoli Ru; Xiana Fan; Tao Wen; Jian Liu
Journal:  Int J Oncol       Date:  2019-11-14       Impact factor: 5.650

7.  Coordination of Di-Acetylated Histone Ligands by the ATAD2 Bromodomain.

Authors:  Chiara M Evans; Margaret Phillips; Kiera L Malone; Marco Tonelli; Gabriel Cornilescu; Claudia Cornilescu; Simon J Holton; Mátyás Gorjánácz; Liping Wang; Samuel Carlson; Jamie C Gay; Jay C Nix; Borries Demeler; John L Markley; Karen C Glass
Journal:  Int J Mol Sci       Date:  2021-08-24       Impact factor: 6.208

Review 8.  Functional Roles of Bromodomain Proteins in Cancer.

Authors:  Samuel P Boyson; Cong Gao; Kathleen Quinn; Joseph Boyd; Hana Paculova; Seth Frietze; Karen C Glass
Journal:  Cancers (Basel)       Date:  2021-07-19       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.